Trial | NCT00304785  Report issue

Title

Latanoprost Versus Fotil

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    36
To compare the intraocular pressure effect and safety of latanoprost 0.005% given every evening versus PTFC given twice daily.
Study Started
May 31
2005
Study Completion
Oct 31
2007
Last Update
Oct 24
2007
Estimate

Drug latanoprost 0.005%

Drug Fotil

Drug placebo

Criteria 

Inclusion Criteria:

adults with primary open-angle or pigment dispersion glaucoma, or ocular hypertension
untreated intraocular pressure should be between 24-36 mm Hg inclusive
visual acuity should be 5/50 or better in both eyes

Exclusion Criteria:

presence of exfoliation syndrome or exfoliation glaucoma
contraindications to study medications
any anticipated change in systemic hypotensive therapy
No Results Posted